Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- ChecktodayChange DetectedA bibliographic note citing Sindher et al. on the management of gastrointestinal symptoms during oral immunotherapy was added, including PubMed attribution. The revision history was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision metadata updated from v3.6.0 to v3.6.2, indicating a minor patch-level update. The change does not affect displayed content or functionality.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page adds recruitment-status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment label and the revision/version from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check29 days agoChange DetectedThe page revision history shows a new revision entry v3.5.5 added and the previous v3.5.4 removed, signaling an update to the page's documents or metadata.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page build/metadata without changing study details.SummaryDifference0.0%

- Check72 days agoChange DetectedThe ClinicalTrials.gov page’s footer revision/version number was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.